Company Filing History:
Years Active: 2016-2022
Title: Chris Sfouggatakis: Innovator in Pharmaceutical Chemistry
Introduction
Chris Sfouggatakis is a notable inventor based in Staten Island, NY (US). He has made significant contributions to the field of pharmaceutical chemistry, holding 2 patents that showcase his innovative approach to drug development.
Latest Patents
His latest patents include a process for the preparation of N-((1R,2S,5R)-5-(-butylamino)-2-((S)-3-(7-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide. This invention generally relates to an improved process for the preparation of N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide. Additionally, he has developed methods for producing festinavir using sulfilimine and sulfoxide processes.
Career Highlights
Chris is currently employed at Bristol-Myers Squibb Company, where he continues to push the boundaries of pharmaceutical innovation. His work has been instrumental in developing new therapeutic compounds that have the potential to improve patient outcomes.
Collaborations
Throughout his career, Chris has collaborated with talented professionals, including Adrian Ortiz and Tamas Benkovics. These collaborations have fostered a creative environment that encourages the exchange of ideas and expertise.
Conclusion
Chris Sfouggatakis is a dedicated inventor whose work in pharmaceutical chemistry has led to valuable innovations. His contributions are paving the way for advancements in drug development and improving healthcare solutions.